Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria

S Mohanty, R Gaind, R Ranjan, M Deb - The Journal of Infection in …, 2010 - jidc.org
Background: Extended-spectrum beta-lactamases (ESBLs) may not always be detected in
routine susceptibility tests. This study reports the performance of the cefepime-clavulanate …

[PDF][PDF] Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria

S Mohanty, R Gaind, R Ranjan, M Deb - 2010 - pdfs.semanticscholar.org
Background: Extended-spectrum beta-lactamases (ESBLs) may not always be detected in
routine susceptibility tests. This study reports the performance of the cefepime-clavulanate …

[PDF][PDF] Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria

S Mohanty, R Gaind, R Ranjan, M Deb - 2010 - scholar.archive.org
Background: Extended-spectrum beta-lactamases (ESBLs) may not always be detected in
routine susceptibility tests. This study reports the performance of the cefepime-clavulanate …

[PDF][PDF] Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria

S Mohanty, R Gaind, R Ranjan, M Deb - 2010 - researchgate.net
Background: Extended-spectrum beta-lactamases (ESBLs) may not always be detected in
routine susceptibility tests. This study reports the performance of the cefepime-clavulanate …

[PDF][PDF] Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria

S Mohanty, R Gaind, R Ranjan, M Deb - 2010 - Citeseer
Background: Extended-spectrum beta-lactamases (ESBLs) may not always be detected in
routine susceptibility tests. This study reports the performance of the cefepime-clavulanate …

[PDF][PDF] Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria

S Mohanty, R Gaind, R Ranjan, M Deb - 2010 - jidc.org
Background: Extended-spectrum beta-lactamases (ESBLs) may not always be detected in
routine susceptibility tests. This study reports the performance of the cefepime-clavulanate …

Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.

S Mohanty, R Gaind, R Ranjan… - Journal of Infection in …, 2010 - search.ebscohost.com
Background: Extended-spectrum beta-lactamases (ESBLs) may not always be detected in
routine susceptibility tests. This study reports the performance of the cefepime-clavulanate …

Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.

S Mohanty, R Gaind, R Ranjan… - Journal of Infection in …, 2009 - europepmc.org
Background Extended-spectrum beta-lactamases (ESBLs) may not always be detected in
routine susceptibility tests. This study reports the performance of the cefepime-clavulanate …

Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria

S Mohanty, R Gaind, R Ranjan… - Journal of Infection in …, 2010 - search.proquest.com
Background: Extended-spectrum beta-lactamases (ESBLs) may not always be detected in
routine susceptibility tests. This study reports the performance of the cefepime-clavulanate …

Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria

S Mohanty, R Gaind, R Ranjan… - Journal of infection in …, 2009 - pubmed.ncbi.nlm.nih.gov
Background Extended-spectrum beta-lactamases (ESBLs) may not always be detected in
routine susceptibility tests. This study reports the performance of the cefepime-clavulanate …